Alpha-Lipoic acid-based PPARgamma agonists for treating inflammatory skin diseases

Archives of Dermatological Research
Meenakshi S VenkatramanStephen C Benson

Abstract

Novel thiazolidinedione derivatives of the potent antioxidant, alpha-lipoic (thioctic, 1,2-dithiolane) acid, were prepared. The prototype N-(2-[4-[2,4-dioxo(1,3-thiazolidin-5-yl)methyl]phenoxy]ethyl)-5-(1,2-dithiolan-3-yl)- N-methylpentanamide (designated BP-1003), and dithioester derivatives thereof were shown to be potent activators of peroxisome proliferator-activated receptor gamma (PPARgamma) (EC(50) range 15-101 nM) and modest activators of PPARalpha (EC(50) 5 microM). Both the relatively hydrophobic dithiolane prototype, BP-1003, and its water-soluble dithioglycinate derivative, BP-1017, were shown to inhibit the proliferation of human keratinocytes and suppress the production of interleukin-2 by human peripheral lymphocytes to a greater extent than the antidiabetic thiazolidinedione, rosiglitazone. Both oral and topical administration of BP-1017 showed significant antiinflammatory effects in the oxazolone-sensitized mouse model of allergic contact dermatitis (ACD). These findings suggest that water-soluble lipoic acid-based thiazolidinediones may be efficacious as oral and topical agents for treating inflammatory skin conditions such as contact dermatitis, atopic dermatitis, and psoriasis.

Citations

Oct 17, 2006·Expert Opinion on Investigational Drugs·James VaraniHarrihar A Pershadsingh
Aug 8, 2014·Expert Opinion on Therapeutic Patents·Maria Koufaki
Feb 25, 2009·Experimental Dermatology·Marianne DemerjianKenneth R Feingold
Apr 13, 2007·American Journal of Clinical Dermatology·Charles N EllisUNKNOWN Avandia Psoriasis Study Group
Sep 7, 2006·Current Opinion in Allergy and Clinical Immunology·William Abramovits, Amy Perlmutter
Apr 11, 2008·Molecular and Cellular Biochemistry·E Philip JesudasonR Jayakumar
Jun 10, 2011·Free Radical Research·Seiichi MatsugoTetsuya Konishi
May 9, 2012·Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society·Huijuan LiaoWeiliam Chen
Jul 7, 2009·Pharmacology & Therapeutics·Andrea Huwiler, Josef Pfeilschifter

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atopic Dermatitis

Atopic dermatitis is a chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. Discover the latest research on atopic dermatitis here.